Gene · 338557
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosis. | Stem Cell Res Ther | 2025 | 41327279 | PubTator, text mining | PubMed |
| Correction to "Phytosphingosine Alleviates Cigarette Smoke-Induced Bronchial Epithelial Cell Senescence in Chronic Obstructive Pulmonary Disease by Targeting the Free Fatty Acid Receptor 4". | MedComm (2020) | 2025 | 41281190 | PubTator, text mining | PubMed |
| Metabolic STAMP for deciphering GPCR-regulated insulin secretion by pancreatic β cells. | bioRxiv | 2025 | 41256453 | PubTator, text mining | PubMed |
| Two decades of FFAR4 biology: From nutrient sensing to therapeutic targeting. | Cell Rep | 2025 | 41241943 | PubTator, text mining | PubMed |
| Long-chain unsaturated free fatty acids control gut motility via nitrergic ganglia of the enteric nervous system. | Proc Natl Acad Sci U S A | 2025 | 41201819 | PubTator, text mining | PubMed |
| Precision Therapeutics Through Bioactive Compounds: Metabolic Reprogramming, Omics Integration, and Drug Repurposing Strategies. | Int J Mol Sci | 2025 | 41155339 | PubTator, text mining | PubMed |
| Exploring the Interplay of Antioxidants, Inflammation, and Oxidative Stress: Mechanisms, Therapeutic Potential, and Clinical Implications. | Diseases | 2025 | 41002745 | PubTator, text mining | PubMed |
| Interaction Between Human Skeletal and Mesenchymal Stem Cells Under Physioxia Enhances Cartilage Organoid Formation: A Phenotypic, Molecular, and Functional Characterization. | Cells | 2025 | 41002388 | PubTator, text mining | PubMed |
| Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning. | Elife | 2025 | 40982369 | PubTator, text mining | PubMed |
| The role of protein S-acylation in vascular injury associated with metabolic disorders. | Front Endocrinol (Lausanne) | 2025 | 40969373 | PubTator, text mining | PubMed |
| Phytosphingosine Alleviates Cigarette Smoke-Induced Bronchial Epithelial Cell Senescence in Chronic Obstructive Pulmonary Disease by Targeting the Free Fatty Acid Receptor 4. | MedComm (2020) | 2025 | 40895192 | PubTator, text mining | PubMed |
| Free fatty acid receptor 4 agonists stimulate insulin secretion via different mechanisms in mouse versus human islets. | bioRxiv | 2025 | 40894772 | PubTator, text mining | PubMed |
| Impact of Obesity on Immunity to the Influenza Virus: Gut Microbiota, Mechanisms, and Novel Therapeutic Strategies. | Diseases | 2025 | 40863240 | PubTator, text mining | PubMed |
| Orbital Fat is an Observation Model to Provide Insights into Adipocyte Hypertrophy and Hyperplasia During White Adipose Tissue Expansion. | Diabetes Metab Syndr Obes | 2025 | 40862228 | PubTator, text mining | PubMed |
| Charting the spatial transcriptome of the human cerebral cortex at single-cell resolution. | Nat Commun | 2025 | 40830090 | PubTator, text mining | PubMed |
| Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy. | Ren Fail | 2025 | 40827435 | PubTator, text mining | PubMed |
| GPR120 agonists for the treatment of type 2 diabetes: an updated patent review (2020-present). | Expert Opin Ther Pat | 2025 | 40789269 | PubTator, text mining | PubMed |
| Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease intervention. | Brain Behav Immun Health | 2025 | 40697975 | PubTator, text mining | PubMed |
| Evaluation of Serum GPR-120 Levels in Diabetic Patients With and Without Nephropathy: A Comparative Study on Lipid and Renal Parameters. | Cureus | 2025 | 40656303 | PubTator, text mining | PubMed |
| The role of free fatty acid receptors activation in pancreatic disorders. | Mol Aspects Med | 2025 | 40652884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338557/papers?page=3